Skip to main content
Egyptian Liver Journal

Table 1 Comparison between the 3 groups regarding demographic and laboratory findings

From: Assessment of serum Resistin in detecting Insulin Resistance and their impact on response to direct acting antiviral in chronic viral hepatitis C patients

Baseline parameter

Naive group (n=20)

Relapser group (n=20)

Control group (n=10)

 

Mean ± SD

Mean ± SD

Mean ± SD

F

p-value

Age (years)

50.150 ± 14.684

43.150 ± 14.050

41.900 ± 13.788

1.649

0.203

BMI(kg/m2)

28.895 ± 4.75

25.695±5.18

23.590±4.12

2.216

0.12

AST (IU/L)

39.750 ± 17.302

34.150 ± 19.288

29 .100 ± 10.785

0.768

0.469

ALT (IU/L)

39.200 ± 18.574

40.500 ± 40.565

38.000 ± 14.142

0.026

0.974

Albumin (g/dl)

3.605 ± 0.373

3.775 ± 0.236

3.730 ± 0.306

1.559

0.221

Total bilirubin (mg/dl)

0.925 ± 0.510

0.840 ± 0.357

0.910 ± 0.341

0.221

0.802

INR

1.173 ± 0.208

1.015 ± 0.158

1.002 ± 0.097

5.418

0.008*

Hemoglobin(g/dL)

10.450 ± 0.774

13.110 ± 1.922

12.320 ± 1.062

18.722

<0.001*

TLC(×103/μL)

7.005 ± 2.173

6.470 ± 2.682

8.590 ± 2.456

2.538

0.090

Platelets(×103/μL)

139.800 ± 57.430

216.600 ± 65.303

289.500 ± 63.400

20.654

<0.001*

HbA1C

6.1 ± 0.3

6 ± 0.5

5.9 ± 0.4

2.443

0.091

Total Cholesterol (mg/dL)

186 ± 20

178 ± 25

159 ± 22

1.54

0.22

LDL (mg/dL)

90 ± 19

84 ± 21

79 ± 27

8.441

0.061

Triglycerides (mg/dL)

132 ± 30

147 ± 24

121 ± 29

10.45

0.07

  1. This table shows no statistical significant difference between the three groups as regards the demographic and laboratory findings of the patients except Hemoglobin and platelets with p value <0.001* and INR with p value <0.008
Back to article page